IRWD FY 2011 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$591M

FY 2011 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$66M+50.2% YoY

Gross Profit

$66M100.0% margin

Operating Income

-$66M-100.4% margin

Net Income

-$65M-98.5% margin

EPS (Diluted)

$-0.65

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$85M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$209M

Total Liabilities

$99M

Stockholders' Equity

$110M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$44M	+50.2%
Gross Profit	$66M	$44M	+50.2%
Operating Income	-$66M	-$61M	-8.8%
Net Income	-$65M	-$53M	-22.4%